Clinical Cancer Genetics Program

Karen Lu, M.D.
Co-Medical Director
Gynecologic Oncology

Banu Arun, M.D.
Co-Medical Director
Breast Medical Oncology


Approximately 5-10% of cancer is inherited. Individuals with a genetic predisposition will have a far higher chance of developing cancer within their lifetime and at an earlier age. Genetic testing can help determine whether a family has a hereditary cancer predisposition syndrome. Individuals who have genetically higher risks to develop certain cancers are recommended to follow high-risk cancer surveillance and management. The Clinical Cancer Genetics Program can coordinate genetic testing and high-risk cancer surveillance for individuals and their families with hereditary cancer syndromes. 

For further information please view our Referral Guidelines: